4//SEC Filing
Bornstein Jonathan 4
Accession 0001942459-24-000021
CIK 0001899287other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:27 PM ET
Size
10.7 KB
Accession
0001942459-24-000021
Insider Transaction Report
Form 4
Bornstein Jonathan
President of Amprius Lab
Transactions
- Sale
Common stock
2024-11-20$1.92/sh−133,536$256,883→ 1,039,187 total(indirect: See Footnote) - Sale
Common stock
2024-11-21$1.96/sh−18,170$35,697→ 454,131 total - Sale
Common stock
2024-11-21$1.96/sh−15,000$29,436→ 1,040,950 total(indirect: See Footnote)
Footnotes (8)
- [F1]The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $1.89 to $1.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F2]These shares of the issuer's common stock, which were previously held directly by the reporting person, were transferred on September 30, 2024 to the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees.
- [F3]The securities are held directly by Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees.
- [F4]The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $1.92 to $2.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]Includes 16,763 shares of the issuer's common stock previously held directly by the reporting person, which were transferred on November 21, 2024 to the Jonathan G. Bornstein and Phyllis S. Brock Trust Agreement, for which the reporting person and his spouse are co-trustees.
- [F6]This transaction was effected pursuant to non-discretionary, sell-to-cover arrangements mandated by the issuer to fund tax withholding obligations in connection with the vesting of restricted stock units.
- [F7]The price reported in Column 4 is an average execution price. These shares were sold in multiple transactions at prices ranging from $1.93 to $2.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F8]These securities are restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock, subject to the applicable vesting schedule and conditions of each restricted stock unit.
Documents
Issuer
Amprius Technologies, Inc.
CIK 0001899287
Entity typeother
Related Parties
1- filerCIK 0001942459
Filing Metadata
- Form type
- 4
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 4:27 PM ET
- Size
- 10.7 KB